管阻塞剂对系统性硬化症中数字的作用:来自前性队列研究的数据
Laura Ross1,2, Dylan Hansen3, Nancy Maltez4
1Department of Medicine, The University of Melbourne, Parkville, VIC, Australia. laura.ross@unimelb.edu.au.
Clinical rheumatology
|November 3, 2023
概括
通道阻塞剂 (CCB) 是常见的系统性硬化症 (SSc) 患者与数字 (DU). 然而,这项研究发现,CCB使用与严重的DU并发症有关,并不能降低患新数字的风险.
科学领域:
- 类风湿病学 类风湿病学
- 血管医学 血管医学
- 临床药理学 临床药理学
背景情况:
- 数字 (DU) 是系统性硬化症 (SSc) 的严重血管并发症.
- 对 DU 的有效治疗方法有限,需要对现有的治疗方案进行研究.
- 通道阻断剂 (CCB) 经常被处方给SSc患者.
研究的目的:
- 评估CCB对SSc患者DU治疗和预防的影响.
- 分析CCB使用与DU临床特征之间的关联.
- 识别SSc中DU发展和复发的风险因素.
主要方法:
- 利用了来自澳大利亚硬化皮肤症队列研究 (ASCS) 的数据,其中有1953名参与者.
- 采用通用估计方程来评估CCB使用和DU风险因素.
- 应用了依赖时间的Cox比例危险模型来评估CCB使用未来的DU发生情况.
主要成果:
- 66%的参与者被处方了CCB,在患有现有的DU的患者中,这种可能性更高.
- CCB使用与严重的DU并发症相关,如慢性DU,住院和数字截肢.
- 使用CCB并没有降低患第一个DU的风险 (HR 0.94,p=0.65).
结论:
- 在ASCS队列中,CCB通常用于SSc管理.
- 使用CCB与SSc.中严重的外周血管表现有关.
- 目前的证据表明,CCB可能无法有效地治疗或预防SSc.的数字.
相关概念视频
Antihypertensive Drugs: Action of Calcium Channel Blockers
533
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
533
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
539
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
539
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
847
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
847
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
18
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
18
Peripheral Artery Disease III: Interprofessional Care
11
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
14
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
14


